Evidence map›Paper›PMID 37554336›Full record

ArticlePeerJ2023

To flea or not to flea: survey of UK companion animal ectoparasiticide usage and activities affecting pathways to the environment.

Rosemary Perkins, Dave Goulson

Abstract read
In one paragraph

Article in PeerJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Transfer of veterinary parasiticides from the fur lining bird's nest to eggs and chicks.Environmental science and pollution research international · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rosemary PerkinsSchool of Life Sciences, University of Sussex, Brighton, United Kingdom.
Dave GoulsonSchool of Life Sciences, University of Sussex, Brighton, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the convenience and efficacy of modern ectoparasiticides, routine prophylactic use has become commonplace for dogs and cats. However, the environmental consequences of this large-scale use are not well-understood, and multiple potential pathways for ectoparasiticides to the environment exist. Of particular concern is the potential for topically applied ectoparasiticides to pass to waterways, both down-the-drain via wastewater treatment plants and directly through swimming. In this online cross-sectional survey of 1,009 UK cat and dog owners, we investigated ectoparasiticide usage and the frequency of activities that are likely to result in transfer of the active substance to the environment, with a focus on pathways to waterways. A total of 603 dog owners and 406 cat owners completed the survey. Amongst dog and cat owners, 86.1% and 91.1% had administered an ectoparasiticide treatment to their pet in the preceding 12 months. Imidacloprid was the most frequently administered ectoparasiticide in both cats and dogs, followed by fluralaner in dogs and fipronil in cats. Eighty-four percent of owners who applied topical ectoparasiticides to their dog said they were aware of product warnings regarding swimming and bathing after application. Spot-on treated dogs were reported to swim significantly less frequently than non spot-on treated dogs (

Indexed as

Cat DiseasesDog DiseasesSiphonapteraAnimalsCatsCross-Sectional StudiesDogsNeonicotinoidsNitro CompoundsPetsTomography, X-Ray ComputedUnited KingdomimidaclopridNeonicotinoidsNitro CompoundsCompanion animalsEmissions pathwaysEnvironmental pollutionParasiticidesPet owner survey

Identifiers

PMID37554336
PMCPMC10405796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.